143 related articles for article (PubMed ID: 38571295)
1. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome.
Vojdani A; Almulla AF; Zhou B; Al-Hakeim HK; Maes M
Acta Neuropsychiatr; 2024 Jun; 36(3):172-184. PubMed ID: 38571295
[TBL] [Abstract][Full Text] [Related]
2. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.
Vojdani A; Vojdani E; Saidara E; Maes M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851614
[TBL] [Abstract][Full Text] [Related]
3. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.
Ablashi DV; Eastman HB; Owen CB; Roman MM; Friedman J; Zabriskie JB; Peterson DL; Pearson GR; Whitman JE
J Clin Virol; 2000 May; 16(3):179-91. PubMed ID: 10738137
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
[TBL] [Abstract][Full Text] [Related]
6. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.
Halpin P; Williams MV; Klimas NG; Fletcher MA; Barnes Z; Ariza ME
J Med Virol; 2017 Sep; 89(9):1636-1645. PubMed ID: 28303641
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.
Patnaik M; Komaroff AL; Conley E; Ojo-Amaize EA; Peter JB
J Infect Dis; 1995 Nov; 172(5):1364-7. PubMed ID: 7594679
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome.
Shikova E; Reshkova V; Kumanova А; Raleva S; Alexandrova D; Capo N; Murovska M; On Behalf Of The European Network On Me/Cfs Euromene
J Med Virol; 2020 Dec; 92(12):3682-3688. PubMed ID: 32129496
[TBL] [Abstract][Full Text] [Related]
9. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
[TBL] [Abstract][Full Text] [Related]
10. Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Schreiner P; Harrer T; Scheibenbogen C; Lamer S; Schlosser A; Naviaux RK; Prusty BK
Immunohorizons; 2020 Apr; 4(4):201-215. PubMed ID: 32327453
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
12. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
Front Immunol; 2022; 13():949787. PubMed ID: 36341457
[TBL] [Abstract][Full Text] [Related]
13. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
[TBL] [Abstract][Full Text] [Related]
14. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
Manian FA
Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
[TBL] [Abstract][Full Text] [Related]
16. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
18. Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers.
Kurano M; Morita Y; Nakano Y; Yokoyama R; Shimura T; Qian C; Xia F; He F; Zheng L; Ohmiya H; Kishi Y; Okada J; Yoshikawa N; Nakajima K; Nagura Y; Okazaki H; Jubishi D; Moriya K; Seto Y; Yasui F; Kohara M; Wakui M; Kawamura T; Kodama T; Yatomi Y
Int Immunopharmacol; 2022 Feb; 103():108491. PubMed ID: 34954559
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]